Corcept Therapeutics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 243.83M 19.91M 2025-06
Alaunos Therapeutics -1127000 1.11M 2024-09
ANI Pharmaceuticals USD 113.48M 10.61M 2025-06
Ardelyx USD 97.86M 15.35M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 191M 36.19M 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
J&J USD 14.6B 816M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Merck USD 12.99B 224M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Novartis USD 10.24B 313M 2024-12
Pacira USD 125.91M 8.71M 2025-06
Pfizer USD 10.88B 248M 2025-06
Supernus Pharmaceuticals USD 127.81M 6.25M 2025-06
TG Therapeutics USD 122.21M 16.9M 2025-06


Corcept Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.